Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!

Lemaitre, Florian

Lemaitre, Florian.

Lemaitre F; Pharmacology Department, Hôpital Pontchaillou, Univ Rennes, CHU de Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR S 1085, 2 rue Henri Le Guilloux, 35033, Rennes Cedex, France. florian.lemaitre@chu-rennes.fr.

Clin Pharmacokinet ; 61(8): 1071-1073, 2022 08.

Article in English | MEDLINE | ID: covidwho-1982400

Subject(s)

HIV Protease Inhibitors; Ritonavir; HIV Protease Inhibitors/therapeutic use; Humans; Immunosuppressive Agents/adverse effects; Ritonavir/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Protease Inhibitors / Ritonavir Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Pharmacokinet Year: 2022 Document Type: Article Affiliation country: S40262-022-01158-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google